Biotechnology
Canada
Unitedstates
Pharmaceuticals
Development
Merger
Therapeutics
M&A Advisory
Lazard
Full Credential Description
Tekmira Pharmaceuticals. Canada, United States. Announced Date 11/01/2015. Closed Date 04/03/2015. Deal value: $750m. Tekmira Pharmaceuticals to merge with and OnCore Biopharma. Industry: Tekmira Pharmaceuticals is a biotechnology company specializing in the development of RNA interference (RNAi) therapeutics.